AGIOS PHARMACEUTICALS, INC. Insider Trading for November 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AGIOS PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AGIOS PHARMACEUTICALS, INC. for November 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 15 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 60.46 | 309 | 18,682 | 81,434 | 81.7 K to 81.4 K (-0.38 %) |
| Nov 15 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 60.46 | 309 | 18,682 | 81,394 | 81.7 K to 81.4 K (-0.38 %) |
| Nov 15 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 59.36 | 691 | 41,018 | 81,743 | 82.4 K to 81.7 K (-0.84 %) |
| Nov 15 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 59.36 | 691 | 41,018 | 81,703 | 82.4 K to 81.7 K (-0.84 %) |
| Nov 15 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 62.07 | 1,000 | 62,070 | 82,434 | 83.4 K to 82.4 K (-1.20 %) |
| Nov 15 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 62.07 | 1,000 | 62,070 | 82,394 | 83.4 K to 82.4 K (-1.20 %) |
| Nov 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 31.64 | 2,146 | 67,899 | 32,185 | |
| Nov 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 61.81 | 946 | 58,472 | 6,264 | 7.2 K to 6.3 K (-13.12 %) |
| Nov 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 63.09 | 900 | 56,781 | 7,210 | 8.1 K to 7.2 K (-11.10 %) |
| Nov 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 63.62 | 200 | 12,724 | 8,110 | 8.3 K to 8.1 K (-2.41 %) |
| Nov 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 65.45 | 100 | 6,545 | 8,310 | 8.4 K to 8.3 K (-1.19 %) |
| Nov 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 31.64 | 2,146 | 67,899 | 8,410 | 6.3 K to 8.4 K (+34.26 %) |
| Nov 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 6,000 | 1,815 | 26,656 | |
| Nov 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 63.32 | 4,260 | 269,743 | 0 | 4.3 K to 0 (-100.00 %) |
| Nov 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 64.64 | 942 | 60,891 | 4,260 | 5.2 K to 4.3 K (-18.11 %) |
| Nov 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 65.42 | 598 | 39,121 | 5,202 | 5.8 K to 5.2 K (-10.31 %) |
| Nov 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 66.75 | 200 | 13,350 | 5,800 | 6 K to 5.8 K (-3.33 %) |
| Nov 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 6,000 | 1,815 | 6,000 | 0 to 6 K |